Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

The P&P office is buzzing

White Papers and Resources | July 4, 2019 | Page & Page Health

P&P are thrilled to attend the Communiqué Awards ceremony this evening.

Patient Centricity on Trial – Trial Patient Focus Group www.patientcentricityontrial.com

Videos and Podcasts | July 2, 2019 | Havas Lynx

Patient Centricity on Trial Focus Group Highlights

Videos and Podcasts | July 2, 2019 | Havas Lynx

Havas Lynx Group lifts a silver Cannes Lion with landmark HIV campaign

Press Releases | July 2, 2019 | Havas Lynx

Communicating a landmark moment for the HIV community has helped a leading healthcare communications agency secure another award at the famous Cannes Lions International Festival of Creativity.

Lucid has been celebrating 10 years of professionalism and unwavering passion

Press Releases | July 1, 2019 | Lucid Group Communications Limited

Lucid recognises, rewards and celebrates long-term service with flowers, vouchers and additional holiday for those who have been with the company for five and ten years. With over 20% of...

Empowering the MS patient through shared decision making

White Papers and Resources | June 26, 2019 | Blue Latitude Health

Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered

Good data is nothing without advocacy

White Papers and Resources | June 26, 2019 | Porterhouse Medical Group

In a world focused on improving outcomes, the days when drugs sold themselves on data alone have long gone. While the need for good data is indisputable, it is now...

Trends in the Pharma Industry – A Lucid Thirsty Thursday Session

Press Releases | June 26, 2019 | Lucid Group Communications Limited

Rob Apollo, Corporate Development Director of Lucid Group, kicked off the first of a series of Thirsty Thursday sessions with a thought-provoking discussion around trends in the pharma industry and...

My MS journey: one patient’s search for innovation

White Papers and Resources | June 25, 2019 | Blue Latitude Health

David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients.

MIT reveals new pill to deliver insulin

White Papers and Resources | June 24, 2019 | Blue Latitude Health

A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...